United States (National)
Not enough data
John Parkinson's coverage focuses on healthcare, pharmaceuticals, government announcements and politics with a particular emphasis on infectious diseases such as COVID-19. This suggests that he would be interested in receiving pitches related to the latest developments in medical research, public health initiatives, vaccine analytics and government decisions impacting healthcare.
Given his focus on citing data and evolving stories within the healthcare sector, John may be particularly receptive to pitches that offer exclusive access to new scientific findings or insights into emerging trends related to infectious diseases.
As there is no specified geographic focus for John's articles, it can be assumed that he covers global issues within the field of healthcare and infectious diseases.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Gavin H. Harris, John Parkinson
Emory’s Gavin Harris, MD, discusses how getting patients this type of treatment is essential to reducing the severity of disease, as well as adapting the four “I’s” algorithm in dealing with high-consequence infectious disease outbreaks.
By: Gavin H. Harris, John Parkinson
In the second episode with Emory’s Gavin Harris, MD, he offers some insights around treating patients with the Andes virus including supportive care as well as investigational antivirals.
By: Lauren Peller, John Parkinson, Peter Charalambous, James Hill
Attorney General Pam Bondi speaks with ABC News, Apr. 25, 2025. (ABC News)
By: Lauren Peller, John Parkinson
LAUREN PELLER and JOHN PARKINSON Democrats on the House Oversight Committee are demanding that Committee Chairman James Comer bring in acting
By: Peter Charalambous, John Parkinson, James Hill
Bondi said Todd Blanche handled the release of the DOJ's Epstein files.
By: John Parkinson, Stefano Bertuzzi
American Society for Microbiology (ASM) CEO Stefano Bertuzzi, PhD, MPH, discusses how they are reorganizing its structure to create more focused scientific divisions while maintaining collaboration across disciplines and improving member engagement.
By: Anu Osinusi, John Parkinson
The FDA approval of this therapy provides the first approved treatment option for chronic hepatitis delta in the US. Anu Osinusi, MD, discusses how this targeted therapy is designed to slow disease progression and improve patient outcomes.
By: Jay O Brien, Allison Pecorin, John Parkinson, Lauren Peller
John Parkinson, Allison Pecorin, Lauren Peller, and Jay O'Brien, ABC News Jun 9, 2026 | 11:44 AM
By: Lauren Peller, James Hill, John Parkinson
Lauren Peller, John Parkinson, and James Hill, ABC News Jun 10, 2026 | 8:54 AM
By: James Hill, Peter Charalambous, John Parkinson, Lauren Peller
Microsoft Co-Founder Bill Gates stops to speak to the media as he arrives to testify at a closed-door interview with the House Oversight Committee
